EuroIntervention PCRonline - Connecting with the community

John A. Ormiston

53 articles

Change in lumen eccentricity and asymmetry after treatment with Absorb bioresorbable vascular scaffolds in the ABSORB cohort B trial: a five-year serial optical coherence tomography imaging study

EuroIntervention 2017;12:e2244-e2252 published online December 2016 published online e-edition April 2017

Published in Volume 12 Number 18, April 2017

DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial

EuroIntervention 2016;12:e1336-e1342 published online ahead of print October 2015 published online e-edition December 2016

Published in Volume 12 Number 11, December 2016

A computational atlas of normal coronary artery anatomy

EuroIntervention 2016;12:845-854

Published in Volume 12 Number 7, September 2016

Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials

EuroIntervention 2016;12:352-355 published online ahead of print September 2015

Published in Volume 12 Number 3, June 2016

Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data

EuroIntervention 2015;11:746-756 published online ahead of print October 2014

Published in Volume 11 Number 7, November 2015

An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition)

EuroIntervention 2015;11:60-67 published online ahead of print February 2015

Published in Volume 11 Number 1, May 2015

The future of BRS in bifurcations

EuroIntervention 2015;11:V188-V192

Published in Volume 11 Supplement V, May 2015

Bioresorbable scaffolds on the bench

EuroIntervention 2015;11:V166-V169

Published in Volume 11 Supplement V, May 2015

Lessons from the real bench: non-BRS

EuroIntervention 2015;11:V27-V30

Published in Volume 11 Supplement V, May 2015

Coronary stent durability and fracture: an independent bench comparison of six contemporary designs using a repetitive bend test

EuroIntervention 2015;10:1449-1455 published online ahead of print November 2014

Published in Volume 10 Number 12, April 2015

Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial

EuroIntervention 2015;10:1383-1390 published online ahead of print May 2014

Published in Volume 10 Number 12, April 2015

A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial

EuroIntervention 2015;10:e1-e8 published online ahead of print August 2014

Published in Volume 10 Number 11, March 2015

Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial

EuroIntervention 2015;10:1299-1306 published online ahead of print April 2014

Published in Volume 10 Number 11, March 2015

Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial

EuroIntervention 2015;10:1288-1298 published online ahead of print February 2014

Published in Volume 10 Number 11, March 2015

Twelve-month results of the Rapid Renal Sympathetic Denervation for Resistant Hypertension Using the OneShot™ Ablation System (RAPID) study

EuroIntervention 2015;10:1221-1229 published online ahead of print December 2014

Published in Volume 10 Number 10, February 2015

Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study

EuroIntervention 2015;10:1213-1220 published online ahead of print December 2014 – DOI: 10.424

Published in Volume 10 Number 10, February 2015

Absorb everolimus-eluting bioresorbable scaffolds in coronary bifurcations: a bench study of deployment, side branch dilatation and post-dilatation strategies

EuroIntervention 2015;10:1169-1177published online ahead of print May 2014

Published in Volume 10 Number 10, February 2015

Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months

EuroIntervention 2014;9:1271-1284 published online ahead of print December 2013

Published in Volume 9 Number 11, March 2014

Two-year follow-up of the NEVO ResElution-I(NEVO RES-I) trial: a randomised, multicentre comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions

EuroIntervention 2013;9:721-729 published online ahead of print March 2013

Published in Volume 9 Number 6, October 2013

The edge vascular response following implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus-eluting stent. First serial follow-up assessment at six months and two years: insights from the first-in-man ABSORB Cohort B and SPIRIT II trials

EuroIntervention 2013;9:709-720 published online ahead of print April 2013

Published in Volume 9 Number 6, October 2013

First-in-human experience using the Volcano VIBE-RX vascular imaging balloon catheter system (Volcano IVUS-guided Balloon Evaluation - New Zealand: VIBE-NZ Study)

EuroIntervention 2013;9:594-600 published online ahead of print January 2013

Published in Volume 9 Number 5, September 2013

Three-year clinical results of the Axxess Biolimus A9 eluting bifurcation stent system: the DIVERGE study

EuroIntervention 2013;9:573-581

Published in Volume 9 Number 5, September 2013

Renal denervation for resistant hypertension using an irrigated radiofrequency balloon: 12-month results from the Renal Hypertension Ablation System (RHAS) trial

EuroIntervention 2013;9:70-74

Published in Volume 9 Number 1, May 2013

First-in-human evaluation of a sirolimus-eluting coronary stent on an integrated delivery system: the DIRECT study

EuroIntervention 2013;9:46-53

Published in Volume 9 Number 1, May 2013

First-in-human use of the OneShot™ renal denervation system from Covidien

EuroIntervention 2013;8:1090-1094

Published in Volume 8 Number 9, January 2013

Head to head comparison of optical coherence tomography, intravascular ultrasound echogenicity and virtual histology for the detection of changes in polymeric struts over time: insights from the ABSORB trial

EuroIntervention 2012;8:352-358 published online ahead of print November 2011

Published in Volume 8 Number 3, July 2012

Stent longitudinal distortion: strut separation (pseudo-fracture) and strut compression (“concertina” effect)

EuroIntervention 2012;8:290-291

Published in Volume 8 Number 2, June 2012

Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study

EuroIntervention 2012;8:214-224

Published in Volume 8 Number 2, June 2012

Four-year clinical follow-up of the ABSORB everolimus-eluting bioresorbable vascular scaffold in patients with de novo coronary artery disease: the ABSORB trial

EuroIntervention 2012;7:1060-1061 publish onlinea ahead of print September 2011

Published in Volume 7 Number 9, January 2012

First-in-human experience with the Medtronic Bifurcation Stent System

EuroIntervention 2011;7:662-669 publish online ahead of print September 2011

Published in Volume 7 Number 6, October 2011

A six-month analysis of quantitative echogenicity of the second generation everolimus-eluting bioresorbable vascular scaffold in relationship with baseline greyscale intravascular ultrasound morphology of the scaffolded plaque

Published in Volume 7 Supplement M, May 2011

Angiographic geometric changes of the lumen vessel wall after bioresorbable vascular scaffolds and metallic platform stents at one-year follow-up

Published in Volume 7 Supplement M, May 2011

2-year follow-up of Nevo RES-elution I, a randomised multicentre comparison of the Nevo Sirolimus-eluting coronary stent system using RES technology with the Taxus Liberté Paclitaxel-eluting stent

Published in Volume 7 Supplement M, May 2011

Comparison between the first and second generation bioresorbable vascular scaffolds: a six month virtual histology study

EuroIntervention 2011;6:1110-1116

Published in Volume 6 Number 9, April 2011

The Petal dedicated bifurcation stent

EuroIntervention Supplement (2010) Vol. 6 (Supplement J) J139-J142

Published in Volume 6 Supplement J, December 2010

Coronary bifurcation stenting: insights from in vitro and virtual bench testing

EuroIntervention Supplement (2010) Vol. 6 (Supplement J) J53-J60

Published in Volume 6 Supplement J, December 2010

Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study

EuroIntervention 2010;6:562-567

Published in Volume 6 Number 5, November 2010

Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial

EuroIntervention 2010;6:447-453 published online ahead of print June 2010

Published in Volume 6 Number 4, September 2010

Very late stent malapposition: the apparent legacy of first generation drug-eluting stent technology

EuroIntervention 2010;6:290-291

Published in Volume 6 Number 2, June 2010

A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study

EuroIntervention 2010;6:195-205

Published in Volume 6 Number 2, June 2010

First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent

EuroIntervention 2010;6:46-53 - DOI10.4244/EIJV6I1A8

Published in Volume 6 Number 1, May 2010

The Szabo technique is not an accurate technique for placement of a stent in ostial coronary lesions: based on 6-month angiographic follow-up, IVUS and 3D bench testing

Published in Volume 6 Supplement H, May 2010

Conformability of bioresorbable Everolimus-eluting scaffolds as compared to metal platform stents

Published in Volume 6 Supplement H, May 2010

Twelve-month follow-up of Nevo RES-elution I, a randomised multicentre comparison of the Nevo Sirolimus-eluting coronary stent system using RES technology with the Taxus Liberté paclitaxel-eluting stent

Published in Volume 6 Supplement H, May 2010

Multicentre, prospective, randomised, single blind, consecutive enrollment evaluation of the Elixir Novolimus-eluting coronary stent system with durable polymer compared to the Endeavor Zotarolimus-eluting coronary stent system: 12-month clinical results and 9-month angiographic and IVUS results - the Excella II study

Published in Volume 6 Supplement H, May 2010

Long-term clinical outcomes with the next-generation Resolute Stent System: a report of the two-year follow-up from the RESOLUTE clinical trial

EuroIntervention 2010;5:692-697

Published in Volume 5 Number 6, January 2010

Everolimus-eluting bioabsorbable stent – Abbot Vascular programme

EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F98-F102

Published in Volume 5 Supplement F, December 2009

Single center, first-in-man study of the Elixir novolimus eluting coronary stent system with durable polymer: 24-month clinical safety and efficacy results

Published in Volume 5 Supplement E, May 2009

Randomised trial comparing the Endeavor zotarolimus-eluting stent and the driver bare-metal stent in single de novo native coronary artery lesions: five-year clinical follow-up of ENDEAVOR II

Published in Volume 5 Supplement E, May 2009

Very late changes in the dilated lesion following coronary balloon angioplasty: a 17 year serial quantitative angiographic study

EuroIntervention 2009;5:121-126

Published in Volume 5 Number 1, May 2009

Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial.

EuroInterv.2009;4:443-448

Published in Volume 4 Number 4, January 2009

EXCELLA™ First-in-Man (FIM) study: safety and efficacy of novolimus-eluting stent in de novo coronary lesions

EuroInterv.2008;4:53-58

Published in Volume 4 Number 1, May 2008

First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novonative coronary artery lesions: Endeavor I Trial

EuroInterv.2005;2:157-164

Published in Volume 1 Number 2, August 2005